Back to all studies
CompletedNCT05103657

BI 1358894 for PTSD

This study is completed in the United States, in Croatia, in Finland, .... It is testing BI 1358894 for PTSD.

PTSDDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether BI 1358894 may be useful for adults experiencing ptsd.

What would participation involve?

Participants may receive BI 1358894, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Croatia, in Finland, and in Germany.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: December 7, 2021
Recruitment status
Completed
Enrollment listed in the registry
318
Sponsor
Boehringer Ingelheim
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Croatia, Finland, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT05103657
Official title
A Phase II, 8-week-treatment, Multicenter, Randomized, Doubleblind, Placebo-controlled, Parallel Group Trial to Evaluate the Efficacy, Tolerability and Safety of Orally Administered BI 1358894 in Patients With Post-Traumatic Stress Disorder (PTSD)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05103657. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Croatia · 5 sites
  • Clincal Hospital Centre Rijeka
    Rijeka
    Site status: Not listed — confirm with the team
  • Polyclinic Neuron
    Zagreb
    Site status: Not listed — confirm with the team
  • Solmed Polyclinic
    Zagreb
    Site status: Not listed — confirm with the team
  • Psychiatric Hospital 'Sveti Ivan'
    Zagreb
    Site status: Not listed — confirm with the team
  • University Psychiatric Hospital Vrapce
    Zagreb
    Site status: Not listed — confirm with the team
Finland · 3 sites
  • Eira Medical Centre
    Helsinki
    Site status: Not listed — confirm with the team
  • Oulu Mentalcare Oy
    Oulu
    Site status: Not listed — confirm with the team
  • Mehiläinen Tampere
    Tampere
    Site status: Not listed — confirm with the team
Germany · 4 sites
  • Universitätsklinikum Aachen, AöR
    Aachen
    Site status: Not listed — confirm with the team
  • Zentralinstitut für seelische Gesundheit
    Mannheim
    Site status: Not listed — confirm with the team
  • Klinikum der Universität München - Campus Innenstadt
    München
    Site status: Not listed — confirm with the team
  • Universitätsklinikum Tübingen
    Tübingen
    Site status: Not listed — confirm with the team
Israel · 1 site
  • The Chaim Sheba Medical Center Tel HaShomer
    Tel Litwinsky
    Site status: Not listed — confirm with the team
Mexico · 4 sites
  • Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada S.C.
    Culiacán
    Site status: Not listed — confirm with the team
  • Hospital Aranda de la Parra
    León
    Site status: Not listed — confirm with the team
  • CIT-Neuropsique S.C
    Monterrey
    Site status: Not listed — confirm with the team
  • BIND Investigaciones S.C.
    San Luis Potosí City
    Site status: Not listed — confirm with the team
Poland · 3 sites
  • MlynowaMed
    Bialystok
    Site status: Not listed — confirm with the team
  • In-Vivo Sp. Z o.o.
    Bydgoszcz
    Site status: Not listed — confirm with the team
  • MTZ Clinical Research Powered by Pratia
    Warsaw
    Site status: Not listed — confirm with the team
Sweden · 4 sites
  • Psykiatri Södra Stockholm
    Enskede
    Site status: Not listed — confirm with the team
  • Psykiatri Affektiva sjukdomar
    Gothenburg
    Site status: Not listed — confirm with the team
  • Psykiatri Sydväst Stockholm
    Huddinge/Stockholm
    Site status: Not listed — confirm with the team
  • Akademiska sjukhuset
    Uppsala
    Site status: Not listed — confirm with the team
United States · 37 sites
  • Woodland International Research Group, Inc.
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Behavioral Research Specialists, LLC
    Glendale, California
    Site status: Not listed — confirm with the team
  • ASCLEPES Research Centers, P.C. dba Alliance Research
    Long Beach, California
    Site status: Not listed — confirm with the team
  • CalNeuro Research Group Inc.
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research
    Riverside, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research, LLC
    San Diego, California
    Site status: Not listed — confirm with the team
  • Clinical Innovations Inc.
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • California Neuroscience Research
    Sherman Oaks, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Research, LLC
    Torrance, California
    Site status: Not listed — confirm with the team
  • Mountain Mind. LLC
    Denver, Colorado
    Site status: Not listed — confirm with the team
  • CNS Clinical Research - Coral Springs
    Coral Springs, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Miami Dade Medical Research Institute, LLC
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Medical Research Group of Central Florida
    Orange City, Florida
    Site status: Not listed — confirm with the team
  • Elixia PHC, LLC
    St. Petersburg, Florida
    Site status: Not listed — confirm with the team
  • Institute for Advanced Medical Research
    Alpharetta, Georgia
    Site status: Not listed — confirm with the team
  • Emory University
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • American Medical Research
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • University of Chicago
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Pharmasite Research, Incorporated
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Boston Clinical Trials
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Sisu BHR, LLC
    Springfield, Massachusetts
    Site status: Not listed — confirm with the team
  • NeuroBehavioral Medicine Group
    Bloomfield Hills, Michigan
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Center For Emotional Fitness
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • Princeton Medical Institute
    Princeton, New Jersey
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research, Inc.
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Insight Clinical Trials
    Beachwood, Ohio
    Site status: Not listed — confirm with the team
  • North Star Medical Research, LLC
    Middleburg Heights, Ohio
    Site status: Not listed — confirm with the team
  • The University of Texas at Austin
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Trials of Dallas, LP
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Relaro Medical Trials, LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Baylor College of Medicine
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Red Oak Psychiatry Associates, PA
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Audie L. Murphy VA Hospital
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Grayline Research Center
    Wichita Falls, Texas
    Site status: Not listed — confirm with the team
  • Salem VA Medical Center
    Salem, Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: This study is open to people aged 18 to 65 who have post-traumatic stress disorder. The purpose of this study is to find out whether a medicine called BI 1358894 improves symptoms in people with post-traumatic stress disorder. Participants are put into 2 groups randomly, which. The study team can confirm the exact objective and what it means for you.

Does this study involve a medication?

This appears to be a medication / drug study involving BI 1358894, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with ptsd; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
CompletedNCT01861847

7-Keto DHEA for PTSD

This study is completed. It focuses on PTSD and currently lists study information in the United States.